Concurrent versus delayed exposure to corticosteroids in equine articular tissues cultured with local anesthetic.
Authors: Boorman Sophie, Hanson R Reid, Velloso Alvarez Ana, Zhong Kevin, Hofmeister Erik, Boone Lindsey H
Journal: Veterinary surgery : VS
Summary
# Editorial Summary This in vitro study evaluated whether timing of corticosteroid administration relative to local anaesthetic injection affects the protective effects on inflamed equine joint tissues. Researchers cultured synovial and osteochondral explants from six horses, stimulated them with inflammatory cytokines (interleukin-1β and tumour necrosis factor-α) to mimic joint inflammation, then treated samples with mepivacaine hydrochloride (a local anaesthetic), triamcinolone acetonide (a corticosteroid), or combinations given either concurrently or with a 6-day separation. Over nine days of culture, they measured markers of cell damage (lactate dehydrogenase), inflammation (prostaglandin E2), cartilage breakdown (matrix metalloproteinase-13) and matrix loss (glycosaminoglycan). Both the concurrent and delayed treatment groups showed equivalent suppression of inflammatory mediators and cartilage-degrading enzymes, with no differences in cytotoxicity or matrix degradation between them. This suggests that clinicians need not delay corticosteroid injection to avoid potential negative interactions with local anaesthetics in intra-articular therapeutic protocols. Given the practical constraints of equine practice and animal welfare considerations, these findings support administering both agents simultaneously when performing joint injections, rather than requiring separate procedures or staged treatments.
Read the full abstract on PubMed
Practical Takeaways
- •In intra-articular injections combining local anesthetic and corticosteroid, delaying corticosteroid administration by 6 days appears to offer no advantage over concurrent injection—timing flexibility may allow clinical convenience without compromising therapeutic benefit.
- •Both mepivacaine and triamcinolone individually suppress inflammatory mediators, suggesting complementary effects; however, mepivacaine's cytotoxic effect warrants consideration of concentration and duration in clinical use.
- •This in vitro model suggests concurrent intra-articular therapy is acceptable from a tissue protection standpoint, but clinical validation in vivo is needed before changing injection protocols.
Key Findings
- •Concurrent and delayed corticosteroid (triamcinolone acetonide) treatment with local anesthetic (mepivacaine) produced equivalent suppression of inflammatory markers PGE2 and MMP-13 in equine articular tissues over 9 days in culture.
- •Mepivacaine alone increased cytotoxicity (LDH) but decreased inflammatory mediators PGE2 and MMP-13 in stimulated explants.
- •Triamcinolone acetonide alone reduced PGE2 and MMP-13 without increasing cytotoxicity markers.
- •No differences in cytotoxicity, inflammation, or matrix degradation were observed between concurrent versus delayed treatment groups.